|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95.36 USD | -1.34% |
|
+5.35% | +174.02% |
| Market Cap | 10.24B 8.99B 8.36B 7.67B 14.42B 986B 14.64B 99.29B 38.79B 485B 38.43B 37.6B 1,676B | P/E 2026 * |
163x | P/E 2027 * | 32.6x |
|---|---|---|---|---|---|
| Enterprise Value | 10.02B 8.8B 8.19B 7.51B 14.12B 965B 14.33B 97.22B 37.98B 475B 37.63B 36.82B 1,641B | EV / Sales 2026 * |
9.96x | EV / Sales 2027 * | 6.51x |
| Free-Float |
65.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Corcept Therapeutics Incorporated
| 1 day | -1.34% | ||
| 1 week | +5.35% | ||
| Current month | +9.67% | ||
| 1 month | +16.92% | ||
| 3 months | +107.03% | ||
| 6 months | +116.83% | ||
| Current year | +174.02% |
| 1 week | 90.07 |  | 97.63 |
| 1 month | 82.31 | | 97.63 |
| Current year | 28.66 | | 97.63 |
| 1 year | 28.66 | | 97.63 |
| 3 years | 20.84 | | 117.33 |
| 5 years | 15.82 | | 117.33 |
| 10 years | 5.24 | | 117.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
CEO | Chief Executive Officer | 68 | 1998-12-31 |
Atabak Mokari
DFI | Director of Finance/CFO | 49 | 2021-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 48 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
BRD | Director/Board Member | 68 | 1998-12-31 |
James Wilson
CHM | Chairman | 82 | 1998-12-31 |
David Mahoney
BRD | Director/Board Member | 71 | 2004-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/15/26 | Sell | Chairman | -10,000 | 0.0093% | ||
| 7/15/26 | Fiscal year | Chief Financial Officer | 120,000 | 0.1118% | ||
| 7/7/26 | Fiscal year | Executive/Senior Manager | 60,000 | 0.0559% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.34% | +5.35% | +41.09% | +292.59% | 10.38B | |
| +0.86% | +1.43% | +48.50% | +160.39% | 1,057B | |
| +1.59% | +4.09% | +55.34% | +53.96% | 624B | |
| +0.95% | +1.91% | +35.91% | +81.14% | 454B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 341B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 297B | |
| -0.14% | +0.33% | +18.70% | +17.64% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 215B | |
| +1.22% | +2.66% | +21.87% | +59.73% | 201B | |
| -1.18% | -3.70% | +14.23% | +66.51% | 162B | |
| Average | +0.20% | +1.60% | +27.70% | +75.99% | 362.43B | |
| Weighted average by Cap. | +0.54% | +1.76% | +35.93% | +78.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.01B 884M 822M 754M 1.42B 96.89B 1.44B 9.76B 3.81B 47.63B 3.78B 3.7B 165B | 1.5B 1.32B 1.23B 1.12B 2.11B 144B 2.14B 14.55B 5.68B 71.01B 5.63B 5.51B 246B |
| Net income | 85.73M 75.29M 70.02M 64.25M 121M 8.26B 123M 831M 325M 4.06B 322M 315M 14.03B | 476M 418M 389M 357M 671M 45.87B 681M 4.62B 1.81B 22.55B 1.79B 1.75B 77.98B |
| Net Debt | -213M -187M -174M -160M -301M -20.55B -305M -2.07B -809M -10.1B -801M -784M -34.93B | -474M -416M -387M -355M -668M -45.67B -678M -4.6B -1.8B -22.45B -1.78B -1.74B -77.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | US$95.36 | -1.34% | 1,003,972 |
| 26-07-23 | US$96.66 | +6.36% | 981,135 |
| 26-07-22 | US$90.88 | -4.99% | 1,378,260 |
| 26-07-21 | US$95.65 | +4.46% | 839,334 |
| 26-07-20 | US$91.57 | +1.16% | 1,612,079 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CORT Stock
Select your edition
All financial news and data tailored to specific country editions
